Series B - NeuroVision Imaging

Series B - NeuroVision Imaging

Investment Firm

Overview

NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.

Announced Date

Jun 29, 2016

Funding Type

Series B

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Wildcat Capital Management

Wildcat Capital Management

Wildcat Capital Management is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

2

Investor Name
Participant InvestorWildcat Capital Management
Participant InvestorLeonard A. Potter

Round Details and Background

NeuroVision Imaging raised $10000000 on 2016-06-29 in Series B

NeuroVision Imaging is a developer of digital imaging and diagnostic solutions for Alzheimer's disease.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 02, 2021
Grant - NeuroVision Imaging
1-undefined
Jan 01, 2014
Venture Round - NeuroVision Imaging
1-undefined
Aug 24, 2021
Grant - NeuroVision Imaging
1-undefined
Jun 29, 2016
Series B - NeuroVision Imaging
2-10.0M

Recent Activity

There is no recent news or activity for this profile.